Research progress on critical viral protease inhibitors for coronaviruses and enteroviruses

Shulei Hu1, Qiuyu Zhong1, Xiong Xie2

  • 1China Pharmaceutical University, 639 Longmian Avenue, Jiangning District, Nanjing 211198, China; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.

Insights

This review explores viral proteases from SARS-CoV-2 and Enterovirus 71 (EV71), focusing on their roles in immune evasion and potential as drug targets. Understanding these viral proteases is key for developing new antiviral therapies against infectious diseases.

Area of Science:

  • Virology
  • Immunology
  • Drug Discovery

Background:

  • Viral infectious diseases pose significant global health challenges.
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes COVID-19, while Enterovirus 71 (EV71) is a primary cause of Hand, Foot, and Mouth Disease (HFMD).
  • Effective direct-acting antiviral drugs are lacking for EV71, and understanding viral mechanisms is crucial for developing new treatments.

Purpose of the Study:

  • To review the current understanding of key viral proteases: SARS-CoV-2 3CLpro and PLpro, and EV71 3Cpro and 2Apro.
  • To analyze the structure, function, and immune modulation activities of these viral proteases.
  • To explore existing and potential inhibitors for these proteases, offering insights for drug development.

Main Methods:

  • Literature review of scientific publications on viral proteases.
  • Analysis of protease structures and functions.
  • Examination of studies on protease-mediated modulation of host innate immunity.
  • Survey of identified inhibitors targeting these viral proteases.

Main Results:

  • Viral proteases play critical roles in viral replication and pathogenesis by cleaving polyproteins.
  • These proteases can actively modulate host innate immune responses to facilitate viral proliferation.
  • Structural and functional data are available for SARS-CoV-2 and EV71 proteases, with some inhibitors identified.

Conclusions:

  • Viral proteases are essential for viral survival and represent promising targets for antiviral drug development.
  • Targeting SARS-CoV-2 3CLpro, PLpro, and EV71 3Cpro/2Apro offers a potential strategy to combat COVID-19 and HFMD.
  • Further research into protease inhibitors could lead to novel therapeutic interventions against these viral infections.

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...